Bond Laboratories (OTC:BNLB) today announced, in a press release, record revenue at its NDS Nutrition (NDS) division of over $1 million for the month ended February 28, 2011 as compared to approximately $688,000 for the comparable period last year, an increase of almost 46 percent. As I write, shares of Bond Labs were down 1 cent at $0.13 per share on light volume of 31,700 shares. The company has a market cap of $8 million and a 52-week range between $0.09 and $0.74 per share.“We are thrilled to have reached this important milestone in the Company’s revenue history and are confident that we are on the road to continued growth and profitability,” stated Bond Laboratories, Inc. CEO, John S. Wilson. “Since the end of 2009 we have nearly doubled the number of retail outlets of the nation’s largest supplement retailer that sell NDS products. Currently entrenched in 630 franchise locations, we continue to expand both our reach as well as the average number of products offered at each store. In the last twelve months alone we have added more than 250 new locations and introduced nine new products, which continue to experience rapid acceptance and strong demand from our growing base of loyal customers.”
Bond Laboratories is a manufacturer of innovative nutritional supplements and beverages. The Company produces and markets products through its NDS Nutrition and Fusion Premium Beverages divisions. NDS’ products number over 60 brands of energy, sports, and dietary supplements. These products are sold directly through specialty health and nutrition retailers, including top-selling products at GNC franchises. Fusion Premium Beverages manufactures functional beverages, including the hangover prevention drink Resurrection. Bond Labs is headquartered in Omaha, Nebraska.
For more information, please visit http://www.bond-labs.com.
No comments:
Post a Comment